Evidence map›Paper›PMID 38778362›Full record

ArticleBMC public health2024

The state of health in the European Union (EU-27) in 2019: a systematic analysis for the Global Burden of Disease study 2019.

João Vasco Santos, Alicia Padron-Monedero, Boris Bikbov, Diana Alecsandra Grad, Dietrich Plass, Enkeleint A Mechili, Federica Gazzelloni, Florian Fischer, Gerhard Sulo, Che Henry Ngwa and 16 more

Abstract read
In one paragraph

Article in BMC public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Food science & nutrition · 2026
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

João Vasco SantosMEDCIDS, Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Porto, Portugal. jvasco.santos@gmail.com.
Alicia Padron-MonederoNational School of Public Health. Instituto de Salud Carlos III, Madrid, Spain.
Boris BikbovScientific-Tools.Org, Bergamo, Italy.
Diana Alecsandra GradDepartment of Public Health, Babeş-Bolyai University, Cluj-Napoca-Napoca, Romania.
Dietrich PlassDepartment for Exposure Assessment and Environmental Health Indicators, Germany Environment Agency, Berlin, Germany.
Enkeleint A MechiliClinic of Social and Family Medicine, School of Medicine, University of Crete, Crete, Greece.
Federica GazzelloniIndependent Researcher, Rome, Italy.
Florian FischerInstitute of Gerontological Health Services and Nursing Research, Ravensburg-Weingarten University of Applied Sciences, Weingarten, Germany.
Gerhard SuloCentre for Disease Burden, Norwegian Institute of Public Health, Oslo, Norway.
Che Henry NgwaDepartment of Epidemiology and Population Health, Faculty of Health Sciences, American University of Beirut, Beirut, Lebanon.
Isabel Noguer-ZambranoNational School of Public Health. Instituto de Salud Carlos III, Madrid, Spain.
José L PeñalvoNational Center for Epidemiology, Instituto de Salud Carlos III, Madrid, Spain.
Juanita A HaagsmaDepartment of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Katarzyna Kissimova-SkarbekDepartment of Health Economics and Social Security, Faculty of Health Sciences, Jagiellonian University Medical College, Krakow, Poland.
Lorenzo MonastaInstitute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy.
Nermin GhithResearch group for Childhood Cancer, Danish Cancer Institute, Danish Cancer Society, Copenhagen, Denmark.
Rodrigo Sarmiento-SuarezNational School of Public Health. Instituto de Salud Carlos III, Madrid, Spain.
Rok HrzicDepartment of International Health, Maastricht University, Care and Public Health Research Institute - CAPHRI, Maastricht, The Netherlands.
Romana HaneefDepartment of Non-Communicable Diseases and Injuries, Santé Publique France, Saint-Maurice, France.
Rónán O'CaoimhDepartment of Medicine, University College Cork, College Road, Cork City, Ireland.
Sarah CuschieriDepartment of Anatomy, Faculty of Medicine and Surgery, University of Malta, Msida, Malta.
Stefania MondelloDepartment of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy.
Zubair KabirSchool of Public Health, University College Cork, Cork, Ireland.
GBD 2019 EU State of Health Collaborators
Alberto FreitasMEDCIDS, Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Porto, Portugal.
Brecht DevleesschauwerDepartment of Epidemiology and Public Health, Sciensano, Brussels, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe European Union (EU) faces many health-related challenges. Burden of diseases information and the resulting trends over time are essential for health planning. This paper reports estimates of disease burden in the EU and individual 27 EU countries in 2019, and compares them with those in 2010.

methodsWe used the Global Burden of Disease 2019 study estimates and 95% uncertainty intervals for the whole EU and each country to evaluate age-standardised death, years of life lost (YLLs), years lived with disability (YLDs) and disability-adjusted life years (DALYs) rates for Level 2 causes, as well as life expectancy and healthy life expectancy (HALE).

resultsIn 2019, the age-standardised death and DALY rates in the EU were 465.8 deaths and 20,251.0 DALYs per 100,000 inhabitants, respectively. Between 2010 and 2019, there were significant decreases in age-standardised death and YLL rates across EU countries. However, YLD rates remained mainly unchanged. The largest decreases in age-standardised DALY rates were observed for "HIV/AIDS and sexually transmitted diseases" and "transport injuries" (each -19%). "Diabetes and kidney diseases" showed a significant increase for age-standardised DALY rates across the EU (3.5%). In addition, "mental disorders" showed an increasing age-standardised YLL rate (14.5%).

conclusionsThere was a clear trend towards improvement in the overall health status of the EU but with differences between countries. EU health policymakers need to address the burden of diseases, paying specific attention to causes such as mental disorders. There are many opportunities for mutual learning among otherwise similar countries with different patterns of disease.

Indexed as

Disability-Adjusted Life YearsEuropean UnionGlobal Burden of DiseaseLife ExpectancyCost of IllnessFemaleHealth StatusHumansMaleEuropean Burden of Disease NetworkEuropean UnionGlobal Burden of DiseasesHealth statusPopulation health

Identifiers

PMID38778362
PMCPMC11110444

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.